SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Universe Pharmaceuticals, Inc. is a pharmaceutical company. The firm is focused on the manufacturing, marketing, sales, and distribution of traditional Chinese medicine derivative products. It also sells biomedical drugs, medical instruments, traditional Chinese medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. The company was founded on March 2, 1998 and is headquartered in Ji'an, China.

Universe Pharmaceuticals INC

UPC is trending due to discussions around its low market cap relative to its substantial cash reserves, sparking speculation about potential buybacks or strategic moves. The community is closely watching for news catalysts, particularly related to potential cryptocurrency ventures, that could trigger a significant price increase. Some traders are drawing comparisons to recent low-float bio stock runners and anticipating a similar breakout for UPC.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull ($BULL) is trending amid a significant price drop, with community members debating whether it's a buying opportunity or a sign of further decline, potentially influenced by an expiring lock-up period. Discussions include speculation about market manipulation, dilution, and comparisons to other brokerage apps like Robinhood ($HOOD). Some traders express long-term bullish sentiment, while others voice frustration and exit their positions.

TMC the metals co., Inc. is a deep-sea minerals exploration company focused on the collection and processing of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone in the Pacific Ocean (CCZ). These nodules contain high grades of four metals (nickel, copper, cobalt, manganese) which can be used as (i) feedstock for battery cathode precursors (nickel, cobalt and manganese sulfates, or intermediate nickel-copper-cobalt matte) for electric vehicles (EV) and renewable energy storage markets, (ii) copper cathode for EV wiring, energy transmission and other applications and (iii) manganese silicate for manganese alloy production required for steel production. The company was founded in 2021 and is headquartered in Vancouver, Canada.

TMC the metals company Inc

TMC is trending as enthusiasm builds around potential government partnerships and the prospects of deep-sea mining. Bullish sentiment is fueled by anticipation of regulatory approvals, particularly the NOAA decision, with investors discussing potential short squeezes. The community is focused on the company's long-term potential in the critical minerals market.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is trending amid new multi-launch deals and anticipation for upcoming milestones, including the "Owl New World" mission and Neutron launch. Community discussions revolve around recent institutional buying activity, potential contract wins, and the company's long-term growth prospects in the expanding space economy. Some traders are also expressing caution about the stock's valuation and recent insider selling.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET is trending due to a recently announced $75 million investment to scale its AI connectivity solutions, sparking excitement about its growth potential in the semiconductor space. The community speculates about the institutional investor and the company's partnerships, while also highlighting POET's potential to disrupt AI data transmission with its optical interposer technology. Discussions also involve potential acquisitions and the stock's long-term growth prospects amid increasing attention from Wall Street Bets.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum (QBTS) is trending amid community discussion around its potential in the quantum computing sector, with some speculating about a potential aerospace customer announcement. Bullish investors are pointing to consolidation at higher prices and possible accumulation by large investors, while bears express concerns about valuation and dilution. The stock is also being discussed in the context of the broader quantum computing "arms race" and its potential impact on national security.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

RGTI is trending due to increased investor interest in the quantum computing sector, further fueled by an analyst raising the price target significantly. Community discussions revolve around the stock's high valuation, potential short squeezes, and the long-term prospects of quantum computing, with some comparing it to past tech bubbles. Despite not being profitable, positive developments, such as new orders and contracts, seem to boost confidence in the company's future growth.

AlphaTON Capital Corp. is a biotechnology company, which engages in the research and development of immuno-oncology therapies for patients with cancer. Its portfolio includes first-in-class invariant natural killer T cell (iNKT) small molecule engagers and best-in-class adenosine antagonists. The company was founded by Gregory H. Bailey and James Mellon in 1973 and is headquartered in Road Town, British Virgin Islands.

AlphaTON Capital Corp.

AlphaTON Capital ($ATON) is trending due to a recent $71 million financing and initial TON token acquisition, sparking discussions about its potential in the Telegram ecosystem. The community is comparing it to previous low-float runners like $GLTO and anticipating further upside, with some speculating about a potential short squeeze. ATON's focus on building a digital asset treasury centered on the TON blockchain is attracting attention as investors seek exposure to the growing Telegram ecosystem.

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation ($ACHR) is trending due to speculation about a potential partnership with Tesla, spurred by suggestive media and shared event space, though no official confirmation exists; this has driven community excitement with some believing management is misleading investors and others remain optimistic about Archer's prospects in the EVTOL space, regardless of Tesla's involvement; community members also cite potential military contracts and analyst upgrades as reasons for optimism.

Galecto, Inc. is a clinical-stage biotechnology company, which engages in developing novel small molecule therapeutics that are designed to target the biological processes that lie at the heart of cancer and fibrotic diseases. The firm is also involved in the development of small molecule inhibitors of galectin-3 and LOXL2. The company was founded by Ulf Jörgen Nilsson, Hakon Leffler, Tariq Sethi, and Hans Thalsgård Schambye in 2011 and is headquartered in Boston, MA.

Galecto Inc

Galecto (GLTO) is trending as traders discuss a potential short squeeze, citing a low float and high borrowing rates for short sellers. The community is urging each other to hold shares, believing shorts will need to cover at a much higher price. Some traders are comparing it to other recent low float runners.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Biotech stocks jump as Makary outlines FDA vision, RBC comments

Investing.com -- Biotech stocks climbed Monday after new FDA Commissioner Dr. Marty Makary laid out a clear and collaborative regulatory strategy that analysts say bodes well for drug developers. In his first major interview since taking office, Makary emphasized pragmatic reforms, faster drug approvals, and modernized use of real-world data across the agency.

Design Therapeutics, Inc. (NASDAQ:DSGN) Director Purchases $66,605.66 in Stock

Design Therapeutics, Inc. (NASDAQ:DSGN  Get Free Report) Director John P. Schmid purchased 17,809 shares of Design Therapeutics stock in a transaction dated Monday, March 25th. The shares were...

Design Therapeutics (DSGN, $3.9) RSI Indicator left the overbought zone on March 27, 2024

This is a signal that DSGN's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...

Design Therapeutics (DSGN, $3.58) RSI Indicator left the overbought zone on March 26, 2024

Equities Analysts Set Expectations for Design Therapeutics, Inc.'s Q1 2024 Earnings (NASDAQ:DSGN)

Design Therapeutics, Inc. (NASDAQ:DSGN  Free Report)  Analysts at Leerink Partnrs boosted their Q1 2024 EPS estimates for shares of Design Therapeutics in a research report issued on...

Design Therapeutics (DSGN, $3.25) RSI Indicator left the overbought zone on March 21, 2024

Design Therapeutics, Inc. (NASDAQ:DSGN) Receives Consensus Rating of "Hold" from Brokerages

Design Therapeutics, Inc. (NASDAQ:DSGN  Get Free Report) has been given a consensus recommendation of Hold by the seven research firms that are currently covering the company...

Design Therapeutics (NASDAQ:DSGN) Receives "Neutral" Rating from Wedbush

Design Therapeutics (NASDAQ:DSGN  Get Free Report)s stock had its neutral rating reissued by Wedbush in a report issued on Wednesday, Benzinga reports. They presently have...

Design Therapeutics Inc (DSGN) Reports Full Year 2023 Financial Results and Pipeline Progress

Advancements in GeneTAC Platform and Strong Cash Position HighlightedRelated Stocks: DSGN...

Design Therapeutics reports Q4 EPS (21c), consensus (31c)

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Design Therapeutics, Inc. operates as a biotechnology company that develops therapies for serious degenerative disorders. It is created to design, develop and commercialize a novel class of small molecule therapeutic candidates (GeneTACs) designed to directly address the underlying basis of genetic disease. The company was founded by Pratik Shah and Aseem Z. Ansari on December 18, 2017 and is headquartered in Carlsbad, CA.

Design Therapeutics Inc

Will JP Morgan Chase ($JPM) beat quarterly earnings?  
 
*Powered by Polymarket

Stocktwits

JPMorgan Chase & Co

) beat quarterly earnings?  
 
*Powered by Polymarket

DSGN Design Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest DSGN News